Medicines Articles
Panacea Biotec, an India-based biotechnology firm, has introduced a generic breast cancer treatment medicine called PacliALL.
The U.S. Food and Drug Administration has granted marketing approval for Corifact Factor XIII Concentrate (Human) for the routine prophylactic treatment of congenital factor XIII(FXIII) deficiency.
The U.S.Food and Drug Administration has approved a novel type of cancer vaccine called Yervoy.
The Ritedose Corp. is voluntarily recalling its 0.083% Albuterol Sulfate Inhalation Solution, 3 mL in 25-, 30- and60-unit dose vials.
Bristol-Myers Squibb’s ipilimumab has shown early promise for helping patients with advanced melanoma that has spread to the brain.
A first-of-its-kind prostate cancer treatment that uses the body’s immune system to fight the disease has been approved by the U.S. Food and Drug Administration.
Octapharma USA has initiated a voluntary withdrawal of all lots of Octagam (immune globulin intravenous [human] 5% liquid preparation) from the U.S. marketplace.